8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 17, 2015)

Filed September 17, 2015For Securities:ELV

Summary

This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) on September 17, 2015, primarily serves as a Regulation FD disclosure. The company's officers were scheduled to meet with securities analysts and investors between September 17 and September 30, 2015. During these interactions, Anthem intended to reaffirm its previously issued financial guidance for the full year 2015. The key takeaway for investors is the reiteration of the company's net income guidance. Anthem expected net income to be greater than $9.55 per share, including greater than $0.45 per share in net unfavorable adjustment items. Excluding these specific adjustments, the company projected adjusted net income to exceed $10.00 per share. This reaffirms confidence in the company's near-term financial performance and outlook as presented in its second quarter 2015 earnings release, with no new significant updates or deviations from prior forecasts.

Key Highlights

  • 1Anthem, Inc. (now Elevance Health) filed an 8-K on September 17, 2015.
  • 2The filing is primarily a Regulation FD disclosure concerning upcoming investor and analyst meetings.
  • 3The company reaffirmed its full-year 2015 net income guidance.
  • 4Full-year 2015 net income was expected to be greater than $9.55 per share.
  • 5Unfavorable adjustment items were projected to be greater than $0.45 per share.
  • 6Excluding these adjustments, adjusted net income was expected to be greater than $10.00 per share.
  • 7The guidance did not include any adjustments beyond those reported in the Q2 2015 earnings release.

Frequently Asked Questions

The main purpose of this 8-K filing is to comply with Regulation FD (Fair Disclosure) by informing investors and securities analysts about the company's upcoming meetings and to reaffirm previously issued financial guidance for the full year 2015. It ensures that all material information is broadly disseminated.

Anthem, Inc. reaffirmed its net income guidance for the full year 2015. They expected net income to be greater than $9.55 per share. This guidance included an expectation of greater than $0.45 per share in net unfavorable adjustment items. Excluding these specific items, the adjusted net income was expected to be greater than $10.00 per share.

No, this filing did not introduce new financial updates or changes to the previously issued guidance. The company explicitly stated that the reaffirmed guidance did not include any adjustments beyond those already reported in their second quarter 2015 earnings release, indicating a confirmation of their existing outlook.

The Cigna acquisition is mentioned as a significant risk factor in the forward-looking statements section. While this 8-K is not primarily about the acquisition, its potential outcome, integration challenges, and the risk of it not closing are listed as key uncertainties that could affect the company's future performance and results.